General

  • Target

    NEAS.9669a1e9157b0159a459b7f6334a5510.pdf

  • Size

    351KB

  • MD5

    9669a1e9157b0159a459b7f6334a5510

  • SHA1

    f13dce28e0979629125af127731c0d2c35b9958f

  • SHA256

    4a058fb48f5b3cd0baef7f3872cb96a837afd37c365e26bdbf32d6a2a2561422

  • SHA512

    3698df1217c95416eacdb639f4b11dc7e14ceb76f0f35263143276c6c7df50a1c3d07288f431488e27206fe447f514818c1d17b11ee5693fea9d9d43528d9abb

  • SSDEEP

    6144:frrejpYnzKiJLxaJUusqZIX4ZHwD9dWYLziXy:frrDz9aWueXgH+WeiC

Score
3/10

Malware Config

Signatures

  • One or more HTTP URLs in PDF identified

    Detects presence of HTTP links in PDF files.

Files

  • NEAS.9669a1e9157b0159a459b7f6334a5510.pdf
    .pdf
    • http://www.emcdda.europa.eu/publications/drug-profiles/benzodiazepine

    • http://www.smmgp.org.uk/

    • http://www.emcdda.europa.eu/attachements.cfm/att_218205_EN_PDU revision.pdf

    • http://.emcdda.europa.eu/activities/action-on-new-drugsen-GB

    • http://www.en-GBemcdda.europa.eu/publications/manuals/tdi-protocol-3.0

    • http://www.emcdda.europa.eu/publications/manuals/tdi-en-GBprotocol-3.0

    • http://www.emcdda.europa.eu/topics/pods/benzodiazepinesen-GBIen-GB

    • http://www.emcdda.europa.eu/en-GBbest-practice

    • http://en.ofdt.fr/publications/tendances/opioid-en-GBsubstitution-treatments-france-recent-data-tendances-94-october-2014/

    • Show all